Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study

ACTA MEDICA INDONESIANA · Vol. 51 No. 2 (2019)

ISSN
2338-2732, 0125-9326
Terbit
2019-08-05
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: increased serum alpha fetoprotein (AFP) levels are often found in patients with advanced hepatocellular carcinoma (HCC). Cluster Differentiation 44 (CD44) and CD90 are stem cell biomarkers that have been assumed as the early HCC markers and associated with onset and progressivity of HCC. The study related to HCC stem cell has not been available in Indonesia. The present study aimed to evaluate the expression of cancer stem cell markers (CD44, CD90) and AFP levels in patients with advanced liver disease. Methods: an observational study was conducted in 41 patients with chronic hepatitis B and/or C infection, liver cirrhosis, and HCC at dr. Saiful Anwar General Hospital. CD44 and CD90 expressions were measured with flow cytometry, and AFP serum levels with ELISA. Data on patient characteristics were evaluated using bivariate and multivariate statistical analysis (One-way ANOVA, Mann-Whitney, Chi-Square, Kruskal-Wallis). Data of CD44, CD90 and AFP were analyzed using Kruskal Wallis test with a significance value of p<0.05, and diagnostic power was analyzed using receiver operating characteristic (ROC). Results: the subjects of our study were 16 patients with chronic hepatitis, 15 patients with liver cirrhosis, and 10 patients with HCC. There was a significant difference regarding CD44+CD90+ and AFP among those three groups (p=0.001; p=0.000) specifically in chronic hepatitis compared to liver cirrhosis (p=0.002; p=0.000) and HCC (p=0.002; p=0.000) respectively. ROC analysis showed the best diagnostic power for the combination of CD44+CD90+ and AFP (AUC=0.981; p=0.000). Conclusion: there are higher expressions of CD44+CD90+ and serum AFP levels in patients with HCC compared to the other two groups (those with chronic hepatitis and liver cirrhosis). The combination of both parameters has the best diagnostic power of HCC.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 221 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Arismunandar ArismunandarAfiliasi tidak diketahui2
Nurhikmah HAfiliasi tidak diketahui2
Supriono SuprionoAfiliasi tidak diketahui2
Mochamad FachrurezaAfiliasi tidak diketahui2
Bogi Pratomo WibowoAfiliasi tidak diketahui2
Irene SaveriaAfiliasi tidak diketahui1
Dian HasanahAfiliasi tidak diketahui1
Amalia Nurul HatinahAfiliasi tidak diketahui1
Rini R BachtiarAfiliasi tidak diketahui1
Irsan HasanAfiliasi tidak diketahui1
Juferdy KurniawanAfiliasi tidak diketahui1
Fauzi YusufAfiliasi tidak diketahui1
Nenny AgustantiAfiliasi tidak diketahui1
Ulfa KholiliAfiliasi tidak diketahui1
Fandy GosalAfiliasi tidak diketahui1
Gita ApriliciaAfiliasi tidak diketahui1
Hery Djagat PurnomoAfiliasi tidak diketahui1
Cecilia O PermatawediAfiliasi tidak diketahui1
Tehar Karo-KaroAfiliasi tidak diketahui1
Haris WiditaAfiliasi tidak diketahui1
Aritantri DarmayaniAfiliasi tidak diketahui1
Arif Nur WidodoAfiliasi tidak diketahui1
Saptino MiroAfiliasi tidak diketahui1
Suyata SuyataAfiliasi tidak diketahui1
Catharina TriwikatmaniAfiliasi tidak diketahui1
I Ketut MariadiAfiliasi tidak diketahui1
Zahra SafiraAfiliasi tidak diketahui1
Andika Agus BudiartoAfiliasi tidak diketahui1
Andi WahedAfiliasi tidak diketahui1
Hasnawi HarisAfiliasi tidak diketahui1
Dian HandayaniAfiliasi tidak diketahui1
Nabila RamadhaniAfiliasi tidak diketahui1
Dewi SantosaningsihAfiliasi tidak diketahui1
Novita Apramadha Kartika SariAfiliasi tidak diketahui1
Natasya Adiba ZahrahAfiliasi tidak diketahui1
Sri WidyartiAfiliasi tidak diketahui1
Aulanni’am Aulanni’amAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study</dc:title>
	<dc:creator>Mustika, Syifa</dc:creator>
	<dc:creator>Wijaya, Hengki</dc:creator>
	<dc:creator>Pratomo, Bogi</dc:creator>
	<dc:subject xml:lang="en-US">AFP</dc:subject>
	<dc:subject xml:lang="en-US">Biomarker</dc:subject>
	<dc:subject xml:lang="en-US">Chronic Hepatitis</dc:subject>
	<dc:subject xml:lang="en-US">liver cirrhosis</dc:subject>
	<dc:subject xml:lang="en-US">HCC</dc:subject>
	<dc:description xml:lang="en-US">Background: increased serum alpha fetoprotein (AFP) levels are often found in patients with advanced hepatocellular carcinoma (HCC). Cluster Differentiation 44 (CD44) and CD90 are stem cell biomarkers that have been assumed as the early HCC markers and associated with onset and progressivity of HCC. The study related to HCC stem cell has not been available in Indonesia. The present study aimed to evaluate the expression of cancer stem cell markers (CD44, CD90) and AFP levels in patients with advanced liver disease. Methods: an observational study was conducted in 41 patients with chronic hepatitis B and/or C infection, liver cirrhosis, and HCC at dr. Saiful Anwar General Hospital. CD44 and CD90 expressions were measured with flow cytometry, and AFP serum levels with ELISA. Data on patient characteristics were evaluated using bivariate and multivariate statistical analysis (One-way ANOVA, Mann-Whitney, Chi-Square, Kruskal-Wallis). Data of CD44, CD90 and AFP were analyzed using Kruskal Wallis test with a significance value of p&amp;lt;0.05, and diagnostic power was analyzed using receiver operating characteristic (ROC). Results: the subjects of our study were 16 patients with chronic hepatitis, 15 patients with liver cirrhosis, and 10 patients with HCC. There was a significant difference regarding CD44+CD90+ and AFP among those three groups (p=0.001; p=0.000) specifically in chronic hepatitis compared to liver cirrhosis (p=0.002; p=0.000) and HCC (p=0.002; p=0.000) respectively. ROC analysis showed the best diagnostic power for the combination of CD44+CD90+ and AFP (AUC=0.981; p=0.000). Conclusion: there are higher expressions of CD44+CD90+ and serum AFP levels in patients with HCC compared to the other two groups (those with chronic hepatitis and liver cirrhosis). The combination of both parameters has the best diagnostic power of HCC.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2019-08-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">The study was cross sectional in design and conducted in 2016-2017 in dr. Saiful Anwar General Hospital Malang, Indonesia. This study had been approved by ethical committee of dr. Saiful Anwar General Hospital Malang. Subjects of the study were adult with</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/718</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 51 No. 2 (2019): Acta Medica Indonesiana; 137</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/718/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>